Erik Richard Ensrud, MD
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ensrud’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$32,408
Medicare paid this office $32,408 for 189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 45 | $6,944 | $91 |
| Muscle electrical test | 71 | $3,411 | $31 |
| Nerve test | 27 | $3,315 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,874 | $59 |
| Return visit (30+ min) | 41 | $2,844 | $65 |
See all 12 services
| Long return visit (40+ min) | 45 | $6,944 | $91 |
| Muscle electrical test | 71 | $3,411 | $31 |
| Nerve test | 27 | $3,315 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,874 | $59 |
| Return visit (30+ min) | 41 | $2,844 | $65 |
| New patient visit (60+ min) | 20 | $2,391 | $120 |
| Nerve test | 29 | $2,249 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,459 | $97 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 73 | $1,101 | $12 |
| Nerve test | 16 | $1,076 | $67 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 24 | $1,067 | $21 |
| Muscle electrical test | 18 | $254 | $11 |
Who their Medicare patients are
189 Original Medicare patients in 2024. Average age 67 · Under 65 29% · 85 and older 6% · Women 42% · Also on Medicaid 23% · Health risk score 1.44. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 65% · Depression 34% · Diabetes 26% · Coronary heart disease 17% · Stroke 16% · Heart failure 15% · Chronic kidney disease 15% · Atrial fibrillation 14% · Cancer 12% · COPD 12% · Dementia 11%.
The office billed $120,940, Medicare allowed $44,287 and paid $32,408; for 602 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 189 | 602 | 67 | 1.44 | $120,940 | $32,408 |
| 2023 | 183 | 380 | 67 | 1.59 | $89,001 | $25,345 |
| 2022 | 206 | 518 | 67 | 1.59 | $116,281 | $34,158 |
| 2021 | 70 | 233 | 70 | 1.45 | $51,739 | $19,370 |
| 2020 | 115 | 277 | 68 | 1.08 | $61,084 | $18,557 |
| 2019 | 171 | 408 | 69 | 1.25 | $89,142 | $26,587 |
| 2018 | 171 | 460 | 68 | 1.26 | $77,204 | $31,526 |
| 2017 | 150 | 284 | 68 | 1.24 | $69,367 | $22,781 |
| 2016 | 154 | 613 | 75 | 1.48 | $148,567 | $45,268 |
| 2015 | 34 | 119 | 71 | 2.13 | $46,233 | $10,334 |
| 2014 | 23 | 34 | 67 | 1.03 | $11,235 | $2,543 |
| 2013 | 60 | 221 | 71 | 1.35 | $83,448 | $19,349 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 45 | $5,372 | $94 |
| Nerve test | 35 | $3,387 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,200 | $56 |
| Return visit (30+ min) | 31 | $2,030 | $65 |
| Nerve test | 15 | $2,002 | $133 |
| Muscle electrical test | 42 | $1,664 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,369 | $98 |
| New patient visit (45+ min) | 12 | $1,098 | $91 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $676 | $22 |
| Muscle electrical test | 24 | $375 | $13 |
2022: 10 services
| Long return visit (40+ min) | 46 | $6,806 | $103 |
| Muscle electrical test | 84 | $4,334 | $34 |
| Nerve test | 27 | $3,830 | $142 |
| Return visit (30+ min) | 42 | $3,225 | $72 |
| Nerve test | 33 | $3,043 | $92 |
| New patient visit (60+ min) | 11 | $1,529 | $139 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 30 | $1,301 | $24 |
| Nerve test | 16 | $1,293 | $81 |
| New patient visit (45+ min) | 11 | $1,024 | $93 |
| Short return visit (20+ min) | 13 | $620 | $48 |
2021: 6 services
| Long return visit (40+ min) | 29 | $6,505 | $112 |
| New patient visit (60+ min) | 36 | $4,972 | $138 |
| Nerve test | 11 | $1,605 | $146 |
| Muscle electrical test | 25 | $1,488 | $35 |
| Short return visit (20+ min) | 11 | $670 | $52 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $588 | $25 |
2020: 9 services
| Muscle electrical test | 63 | $3,606 | $36 |
| New patient visit (60+ min) | 23 | $2,943 | $128 |
| Long return visit (40+ min) | 26 | $2,408 | $80 |
| Nerve test | 13 | $1,935 | $149 |
| Nerve test | 15 | $1,477 | $98 |
| Return visit (30+ min) | 20 | $1,416 | $62 |
| Nerve test | 16 | $1,233 | $77 |
| Nerve test | 17 | $1,099 | $65 |
| New patient visit (45+ min) | 11 | $1,074 | $98 |
2019: 10 services
| Muscle electrical test | 49 | $2,797 | $37 |
| Nerve test | 22 | $2,116 | $88 |
| New patient visit (45+ min) | 21 | $2,099 | $100 |
| New patient visit (60+ min) | 15 | $2,032 | $135 |
| Return visit (30+ min) | 27 | $2,007 | $59 |
| New patient visit (45+ min) | 23 | $1,953 | $85 |
| Muscle electrical test | 36 | $1,806 | $35 |
| Long return visit (40+ min) | 16 | $1,614 | $85 |
| Return visit (30+ min) | 19 | $878 | $44 |
| Nerve test | 13 | $539 | $41 |
2018: 9 services
| New patient visit (60+ min) | 45 | $5,817 | $129 |
| Long return visit (40+ min) | 32 | $3,914 | $85 |
| New patient visit (45+ min) | 38 | $3,854 | $101 |
| Muscle electrical test | 62 | $3,247 | $36 |
| Return visit (30+ min) | 34 | $2,449 | $58 |
| Nerve test | 23 | $1,518 | $63 |
| Nerve test | 17 | $1,497 | $83 |
| Nerve test | 12 | $1,319 | $110 |
| Short return visit (20+ min) | 20 | $964 | $40 |
2017: 8 services
| Muscle electrical test | 41 | $3,119 | $54 |
| Nerve test | 32 | $3,116 | $97 |
| Nerve test | 13 | $1,766 | $136 |
| New patient visit (45+ min) | 17 | $1,740 | $102 |
| New patient visit (60+ min) | 11 | $1,421 | $129 |
| Long return visit (40+ min) | 11 | $1,409 | $94 |
| Nerve test | 14 | $1,187 | $85 |
| Return visit (30+ min) | 11 | $851 | $71 |
2016: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $16,096 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $9,904 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,177 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,507 | $157 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,029 | $56 |
| Nerve test | 11 | $1,259 | $114 |
| Long return visit (40+ min) | 11 | $1,241 | $113 |
| Muscle electrical test | 13 | $1,233 | $73 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,085 | $83 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $5,387 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,163 | $166 |
| Hospital discharge day management, 30 minutes or less | 11 | $666 | $61 |
2014: 2 services
| Long return visit (40+ min) | 14 | $1,546 | $86 |
| Return visit (30+ min) | 11 | $775 | $65 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $10,582 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,234 | $162 |
| Long return visit (40+ min) | 16 | $1,772 | $84 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,643 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $631 | $57 |
Medicaid work
$2,301 in 2024
Medicaid paid $2,301 for 34 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital outpatient clinic visit for assessment and management of a patient | 34 | $2,301 |
| 2024 | 34 | 1 | 20 | $2,301 |
| 2023 | 72 | 1 | 19 | $4,458 |
| 2022 | 62 | 2 | 16 | $2,886 |
| 2020 | 119 | 1 | 19 | $5,655 |
| 2019 | 186 | 2 | 20 | $5,451 |
| 2018 | 79 | 1 | 21 | $2,408 |
See the largest Medicaid services in earlier years
2023
| Hospital outpatient clinic visit for assessment and management of a patient | 72 | $4,458 |
2022
| Muscle electrical test | 33 | $1,539 |
| Hospital outpatient clinic visit for assessment and management of a patient | 29 | $1,347 |
2020
| Muscle electrical test | 119 | $5,655 |
2019
| Muscle electrical test | 170 | $4,613 |
| Hospital outpatient clinic visit for assessment and management of a patient | 16 | $838 |
2018
| Muscle electrical test | 79 | $2,408 |
Drugs they prescribed that Part D paid
$2,341,920
Pharmacies billed $2,341,920 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 366) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
190 generic and 176 brand-name prescriptions · $2,341,920 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyvgart | None | 13 | $931,516 | $71,655 |
| Radicava Ors | None | 49 | $719,129 | $14,676 |
| Gammagard Liquid | Immune globulin | 45 | $194,456 | $4,321 |
| Gammaked | Immune globulin | 11 | $177,461 | $16,133 |
| Privigen | Immune globulin | 16 | $136,447 | $8,528 |
See all 13 drugs
| Vyvgart | None | 13 | $931,516 | $71,655 |
| Radicava Ors | None | 49 | $719,129 | $14,676 |
| Gammagard Liquid | Immune globulin | 45 | $194,456 | $4,321 |
| Gammaked | Immune globulin | 11 | $177,461 | $16,133 |
| Privigen | Immune globulin | 16 | $136,447 | $8,528 |
| Riluzole | None | 30 | $7,708 | $257 |
| Pyridostigmine | None | 32 | $3,637 | $114 |
| Mexiletine | None | 11 | $245 | $22 |
| Sodium Chloride | None | 25 | $199 | $8 |
| Nortriptyline | None | 22 | $198 | $9 |
| Prednisone | None | 24 | $172 | $7 |
| Gabapentin | None | 11 | $107 | $10 |
| Famotidine | None | 13 | $16 | $1 |
Year by year
| 2024 | 366 | 45 | 0% (0) | 48% | $2,341,920 |
| 2023 | 412 | 43 | 0% (0) | 54% | $2,894,135 |
| 2022 | 297 | 40 | 0% (0) | 47% | $1,788,751 |
| 2021 | 60 | 14 | 0% (0) | None | $51,590 |
| 2019 | 22 | None | 0% (0) | 0% | $188 |
| 2018 | 27 | None | 0% (0) | 0% | $225 |
| 2017 | 18 | 12 | None | None | $544 |
| 2016 | 62 | 15 | None | None | $2,998 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Vyvgart | None | 20 | $1,426,950 | $71,347 |
| Radicava Ors | None | 28 | $372,933 | $13,319 |
| Gammagard Liquid | Immune globulin | 72 | $356,881 | $4,957 |
| Gammaked | Immune globulin | 15 | $320,278 | $21,352 |
| Privigen | Immune globulin | 26 | $206,695 | $7,950 |
| Pyridostigmine | None | 29 | $2,537 | $87 |
| Riluzole | None | 13 | $2,371 | $182 |
| Sodium Chloride | None | 37 | $460 | $12 |
| Prednisone | None | 30 | $319 | $11 |
| Baclofen | None | 15 | $262 | $17 |
| Propranolol | None | 12 | $235 | $20 |
| Ondansetron | None | 15 | $134 | $9 |
2022: 11 drugs
| Vyvgart | None | 11 | $751,222 | $68,293 |
| Gammagard Liquid | Immune globulin | 37 | $359,611 | $9,719 |
| Gammaked | Immune globulin | 21 | $289,429 | $13,782 |
| Radicava Ors | None | 18 | $252,350 | $14,019 |
| Privigen | Immune globulin | 12 | $74,086 | $6,174 |
| Pyridostigmine | None | 37 | $2,890 | $78 |
| Riluzole | None | 14 | $1,586 | $113 |
| Gabapentin | None | 12 | $340 | $28 |
| Sodium Chloride | None | 26 | $312 | $12 |
| Prednisone | None | 23 | $258 | $11 |
| Ondansetron | None | 16 | $125 | $8 |
2021: 1 drug
| Gabapentin | 12 | $208 | $17 |
2019: 1 drug
| Gabapentin | 20 | $138 | $7 |
2018: 1 drug
| Gabapentin | 23 | $188 | $8 |
Money from drug and device companies
$2,025 in 2023
| 2023 | 1 | 2 | $2,013 | $2,025 |
| 2022 | 1 | 7 | $2,500 | $2,737 |
| 2021 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Argenx US | Vyvgart | $2,025 | 2 payments
|
See all 2 published payments
| Argenx US | Meals · 2023-03-19 | None | $13 |
| Argenx US | Consulting · 2023-02-09 | Vyvgart | $2,013 |
See earlier years (2022, 2021)
2022: $2,737
| Argenx US | Vyvgart | $2,737 | 7 payments
|
2021: $19
| Biohaven Pharmaceuticals | Nurtec Odt | $19 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Alexion Pharmaceuticals, Inc. · Long Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies · 2023 | Their institution | $7,543 |
| Alexion Pharmaceuticals, Inc. · Long Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies · 2024 | Their institution | $4,938 |
| Alexion Pharmaceuticals, Inc. · Long Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies · 2025 | Their institution | $4,194 |
Professional record
- NPI
- 1982658738
- Licence
- MO 2021049178, OR MD181780
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MO 200094637, TX 172255501
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 204R00000X (204R00000X); Federal specialty code 208100000X (208100000X); Federal specialty code 2081N0008X (2081N0008X); Federal specialty code 2084N0008X (2084N0008X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-19
- NPI last updated
- 2026-03-17
- NPI record certified
- 2026-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1020 Hitt St, Columbia, MO, 65212
This office lists an electronic records connection.